Format

Send to

Choose Destination
Bull Cancer. 2019 Jan 22. pii: S0007-4551(19)30018-9. doi: 10.1016/j.bulcan.2019.01.002. [Epub ahead of print]

[Update of the recommendations of good clinical practice for the use of PET in oncology].

[Article in French]

Author information

1
CHRU de Brest, service de médecine nucléaire, 2, avenue Foch, 29609 Brest cedex, France. Electronic address: pierre-yves.salaun@chu-brest.fr.
2
CHRU de Brest, service de médecine nucléaire, 2, avenue Foch, 29609 Brest cedex, France. Electronic address: ronan.abgral@chu-brest.fr.
3
Service d'ORL et de chirurgie cervico-faciale, 1, place A.-Ricordeau Hôtel-Dieu, 44093 Nantes cedex, France. Electronic address: olivier.malard@chu-nantes.fr.
4
CHRU de Brest, service de médecine nucléaire, 2, avenue Foch, 29609 Brest cedex, France.
5
CHRU de Brest, service d'oncologie thoracique, 2, avenue Foch, 29609 Brest cedex, France. Electronic address: gilles.quere@chu-brest.fr.
6
Groupe hospitalier Paris Centre, hôpital Cochin, service de médecine nucléaire, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. Electronic address: myriam.wartski@aphp.fr.
7
Groupe hospitalier Paris Centre, hôpital Cochin, service de gastro-entérologie, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. Electronic address: romain.coriat@aphp.fr.
8
CHU de Bordeaux, hôpital Haut-Lévêque, service de médecine nucléaire, avenue Magellan, 33604 Pessac, France. Electronic address: elif.hindie@chu-bordeaux.fr.
9
AP-HM, service de médecine nucléaire, 80, rue Brochier, 13005 Marseille, France. Electronic address: David.TAIEB@ap-hm.fr.
10
CHU de Bordeaux, hôpital Haut-Lévêque, service d'endocrinologie, avenue Magellan, 33604 Pessac, France. Electronic address: antoine.tabarin@chu-bordeaux.fr.
11
Centre Eugène-Marquis, service de médecine nucléaire, avenue de la Bataille-Flandres-Dunkerque, 35000 Rennes, France. Electronic address: antoine.girard.89@orange.fr.
12
Centre cardiologique du nord, service de médecine nucléaire, 32-36, rue des Moulins-Gémeaux, 93200 Saint-Denis, France. Electronic address: grellier.jf@gmail.com.
13
Institut Paoli-Calmettes, service de médecine nucléaire, 232, boulevard Sainte-Marguerite, 13009 Marseille, France. Electronic address: BRENOTROSSII@ipc.unicancer.fr.
14
AP-HP, hôpital Saint-Louis, service de médecine nucléaire, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: dgroheux@yahoo.fr.
15
Institut de cancérologie de l'Ouest (ICO), service de médecin nucléaire, site René-Gauducheau, boulevard Professeur-Jacques-Monod, 44800 Saint-Herblain, France. Electronic address: Caroline.Rousseau@ico.unicancer.fr.
16
University of Turin, division of nuclear medicine, department of medical sciences, Corso AM Dogliotti 14, 10126 Torino, Italie. Electronic address: desiree.deandreis@unito.it.
17
CHU Dijon Bourgogne, hôpital François-Mitterrand, service de médecine nucléaire, 2, boulevard Maréchal-de-Lattre-de-Tassigny, 21000 Dijon, France. Electronic address: jean-louis.alberini@chu-dijon.fr.
18
CHU de Nantes, service de médecine nucléaire, 1, place A.-Ricordeau Hôtel-Dieu, 44093 Nantes cedex, France. Electronic address: caroline.milin@chu-nantes.fr.
19
AP-HP/U-PEC, hôpitaux universitaires Henri-Mondor, service de médecine nucléaire, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France. Electronic address: emmanuel.itti@aphp.fr.
20
CHU Dijon Bourgogne, hôpital François-Mitterrand, service d'hématologie clinique, 2, boulevard Maréchal-de-Lattre-de-Tassigny, 21000 Dijon, France. Electronic address: olivier.casasnovas@chu-dijon.fr.
21
CHU de Nantes, service de médecine nucléaire, 1, place A.-Ricordeau Hôtel-Dieu, 44093 Nantes cedex, France. Electronic address: francoise.bodere@chu-nantes.fr.
22
CHU de Nantes, service d'hématologie clinique, 5, allée de l'île-Gloriette, 44093 Nantes cedex 01, France. Electronic address: philippe.moreau@chu-nantes.fr.
23
CHRU de Brest, centre du traitement de la douleur, boulevard Tanguy-Prigent, 29609 Brest cedex, France. Electronic address: arnaudphilip0@gmail.com.
24
Institut Gustave-Roussy, service de radiologie, 39, rue Camille-Desmoulins, 94805 Villejuif, France. Electronic address: Corinne.BALLEYGUIER@gustaveroussy.fr.
25
CHU Henri-Mondor, service d'imagerie médicale, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil cedex, France. Electronic address: alain.luciani@aphp.fr.
26
Jean-Perrin Comprehensive Cancer Center, service de médecin nucléaire, 58, rue Montalembert, 63100 Clermont-Ferrand, France. Electronic address: Florent.CACHIN@clermont.unicancer.fr.

Abstract

Positron Emission Tomography (PET) is a functional nuclear medicine imaging technique which clinical value in oncology has been demonstrated. PET indications are constantly evolving, thanks to the contribution of research. The use of PET in oncology has been the subject of recommendations according to the Standard-Options-Recommendations methodology from the Fédération Nationale des Centres de Lutte Contre le Cancer in 2002, updated in 2003. However, many scientific works have been published since 2003 and new tracers have also obtained a marketing authorization in France. The objective of this work was therefore to update the recommendations established in 2003. In this context, in collaboration with the Société française de médecine nucléaire, a working group was set up for the development of good clinical practice recommendations under the HAS-INCA methodological label. The present document is issued from a comprehensive review of the literature and rigorous appraisal by a panel of national experts, organ specialists, clinical oncologists, surgeons, and imaging specialists. It is intended to be used as a guide to decision-making for those oncology teams that are able to manage patients in various situations in which the AMM label is not sufficiently precise.

KEYWORDS:

Oncologie; Oncology; Positron emission tomography; Recommandation; Recommendation; Tomographie par émission de positon

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center